Literature DB >> 23558727

Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus.

Blanche P Alter1, Neelam Giri, Sharon A Savage, Wim G V Quint, Maurits N C de Koning, Mark Schiffman.   

Abstract

Patients with Fanconi anemia (FA) and dyskeratosis congenita (DC) are at high risk of head and neck squamous cell carcinomas (HNSCC) and anogenital squamous cell carcinomas (SCC). In the general population, these sites (particularly oropharyngeal SCC) may be associated with infection with human papillomavirus (HPV). In FA and DC, however, the majority of HNSCC occur in the oral cavity. We investigated the HPV status of HNSCC and vulvar SCC from nine patients with FA and four with DC using a very sensitive PCR assay, and found HPV16 DNA in only a single vulvar tumor from one patient with FA, and in none of the HNSCC. These results suggest that HPV may not be the cause of SCC in patients with FA or DC, and that vaccination may not reduce the incidence of HNSCC in these patients.
Copyright © 2013 UICC.

Entities:  

Keywords:  Fanconi anemia; dyskeratosis congenita; human papillomavirus; squamous cell carcinoma

Mesh:

Year:  2013        PMID: 23558727      PMCID: PMC3707947          DOI: 10.1002/ijc.28157

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

Review 2.  Pathophysiology and management of inherited bone marrow failure syndromes.

Authors:  Akiko Shimamura; Blanche P Alter
Journal:  Blood Rev       Date:  2010-04-24       Impact factor: 8.250

3.  The use of human papillomavirus seroepidemiology to inform vaccine policy.

Authors:  Mark Schiffman; Mahboobeh Safaeian; Nicolas Wentzensen
Journal:  Sex Transm Dis       Date:  2009-11       Impact factor: 2.830

4.  Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.

Authors:  Mark W Lingen; Weihong Xiao; Alessandra Schmitt; Bo Jiang; Robert Pickard; Paul Kreinbrink; Bayardo Perez-Ordonez; Richard C Jordan; Maura L Gillison
Journal:  Oral Oncol       Date:  2012-07-28       Impact factor: 5.337

Review 5.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 6.  HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

Authors:  Maura L Gillison; Anil K Chaturvedi; Douglas R Lowy
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

7.  Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma.

Authors:  Maurits N C de Koning; Wim G V Quint; Edyta C Pirog
Journal:  Mod Pathol       Date:  2008-01-11       Impact factor: 7.842

8.  A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay.

Authors:  Dirk van Alewijk; Bernhard Kleter; Maarten Vent; Jean-Marc Delroisse; Maurits de Koning; Leen-Jan van Doorn; Wim Quint; Brigitte Colau
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

9.  Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.

Authors:  David I Kutler; Volkert B Wreesmann; Andy Goberdhan; Leah Ben-Porat; Jaya Satagopan; Ivan Ngai; Andrew G Huvos; Philip Giampietro; Orna Levran; Kanan Pujara; Rafaella Diotti; Diane Carlson; Laryssa A Huryn; Arleen D Auerbach; Bhuvanesh Singh
Journal:  J Natl Cancer Inst       Date:  2003-11-19       Impact factor: 13.506

10.  Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.

Authors:  Hester J T van Zeeburg; Peter J F Snijders; Thijs Wu; Eliane Gluckman; Jean Soulier; Jordi Surralles; Maria Castella; Jacqueline E van der Wal; Johan Wennerberg; Joseph Califano; Eunike Velleuer; Ralf Dietrich; Wolfram Ebell; Elisabeth Bloemena; Hans Joenje; C René Leemans; Ruud H Brakenhoff
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

View more
  29 in total

1.  Detection of human papillomavirus in the oral cavities of persons with Fanconi anemia.

Authors:  R L Winer; C E Huang; S Cherne; J E Stern; M S Butsch Kovacic; P A Mehta; S L Sauter; D A Galloway; R A Katzenellenbogen
Journal:  Oral Dis       Date:  2014-09-18       Impact factor: 3.511

Review 2.  Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.

Authors:  Ronald S Cheung; Toshiyasu Taniguchi
Journal:  Int J Hematol       Date:  2017-06-19       Impact factor: 2.490

Review 3.  Inherited bone marrow failure syndromes: considerations pre- and posttransplant.

Authors:  Blanche P Alter
Journal:  Blood       Date:  2017-11-23       Impact factor: 22.113

Review 4.  Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.

Authors:  Andrew C Dietz; Sharon A Savage; Adrianna Vlachos; Parinda A Mehta; Dorine Bresters; Jakub Tolar; Carmem Bonfim; Jean Hugues Dalle; Josu de la Fuente; Roderick Skinner; Farid Boulad; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

Review 5.  Inherited bone marrow failure syndromes: considerations pre- and posttransplant.

Authors:  Blanche P Alter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.

Authors:  Parinda A Mehta; Sharon Sauter; Xue Zhang; Stella M Davies; Suzanne I Wells; Kasiani C Myers; Gitika Panicker; Elizabeth R Unger; Melinda Butsch Kovacic
Journal:  Vaccine       Date:  2017-10-16       Impact factor: 3.641

7.  Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes.

Authors:  Blanche P Alter; Neelam Giri; Yuanji Pan; Sharon A Savage; Ligia A Pinto
Journal:  Vaccine       Date:  2013-12-02       Impact factor: 3.641

8.  The Salivary Microbiome and Oral Cancer Risk: a Pilot Study in Fanconi Anemia.

Authors:  C P Furquim; G M S Soares; L L Ribeiro; M A Azcarate-Peril; N Butz; J Roach; K Moss; C Bonfim; C C Torres-Pereira; F R F Teles
Journal:  J Dent Res       Date:  2016-11-13       Impact factor: 6.116

9.  High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells.

Authors:  Timothy M Chlon; Elizabeth E Hoskins; Christopher N Mayhew; Kathryn A Wikenheiser-Brokamp; Stella M Davies; Parinda Mehta; Kasiani C Myers; James M Wells; Susanne I Wells
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

10.  In reference to Natural history and management of fanconi anemia patients with head and neck cancer: A 10-year follow-up.

Authors:  Blanche P Alter; Philip S Rosenberg
Journal:  Laryngoscope       Date:  2016-01-23       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.